EUVIMEDEUVIMED entdecken
FallberichtSystematische Übersicht

Amiodarone‐Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports

Paawanjot Kaur, Ashampreet Kaur, Amitasha Sinha, Waseem Khaliq, Igor Dumic, Amteshwar Singh iD

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2330 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Paawanjot Kaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dayanand Medical College, Ludhiana, India. Hauptthemen laut MEDLINE: Amiodarone, Atrial Fibrillation, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including neurotoxicity. While ataxia, neuropathy, and tremors are more commonly seen forms of amiodarone neurotoxicity, very few cases of nystagmus are reported. We report the case of an 86‐year‐old man who presented with abrupt‐onset ataxia, dizziness, and inability to ambulate, 10 days after initiating amiodarone for atrial fibrillation. His examination revealed gaze‐evoked nystagmus along with features of cerebellar dysfunction. After excluding other etiologies, amiodarone was stopped. His nystagmus resolved, and his ataxia improved within 48 h of stopping amiodarone. Due to the rarity of this drug‐induced adverse effect, we performed a systematic review of available case reports in the literature (PubMed and Scopus) using Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and presented our findings. Nystagmus is a rarely reported adverse effect of amiodarone, which can occur within days to months of starting the medication. Treatment includes stopping the drug and monitoring for resolution of nystagmus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaroneAtrial FibrillationDrug-Related Side Effects and Adverse ReactionsAged, 80 and overHumansMaleAnti-Arrhythmia AgentsAtaxiaDizzinessTremorCase Reports as Topic

Stichwörter der Autor:innen

amiodaroneataxianeurotoxicitynystagmus

Substanzen

AmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Dayanand Medical College, Ludhiana, India.
  • Sri Guru Ramdas Institute of Medical Sciences & Research, Amritsar, India.
  • Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
  • Mayo Clinic Alix School of Medicine, Rochester, MN, USA.

ORCID-Profile: Amteshwar Singh

Zitieren

APA

Kaur, P., Kaur, A., Sinha, A., Khaliq, W., Dumic, I., & Singh, A. (2023). Amiodarone‐Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2330

Vancouver

Kaur P, Kaur A, Sinha A, Khaliq W, Dumic I, Singh A. Amiodarone‐Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2330

BibTeX
@article{Kaur2023,
  author = {Kaur, Paawanjot and Kaur, Ashampreet and Sinha, Amitasha and Khaliq, Waseem and Dumic, Igor and Singh, Amteshwar},
  title = {Amiodarone‐Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2330}
}
Kostenlos starten →